The abstract submission deadline has passed. Thank you to everyone who sent in submissions; they are currently being reviewed.

Research eligible for submission must demonstrate the impact of endocrine disrupting chemicals on women’s health or successful outcomes in the prevention or treatment of endocrine disrupting chemicals’ impact on women’s health.

Selected abstracts will be chosen to participate in the virtual poster session during the symposium.

All selected abstracts will be made available on the symposium website.

Deadlines:

Abstract Submission Deadline: Friday, May 19, 2023
Notification of Acceptance: Early June 2023
Virtual Presentation Deadline: July 7, 2023
Symposium: July 18-19, 2023